Literature DB >> 4083898

Preparation and characterization of polyclonal and monoclonal antibodies against human aromatase cytochrome P-450 (P-450AROM), and their use in its purification.

C R Mendelson, E E Wright, C T Evans, J C Porter, E R Simpson.   

Abstract

Aromatase cytochrome P-450 (P-450AROM) was partially purified from human placental microsomes by hydrophobic affinity chromatography using Phenyl-Sepharose and ion-exchange chromatography on DEAE-cellulose. The resulting preparation had a specific activity of 2 nmol/mg protein with respect to cytochrome P-450 content and displayed a type I difference spectrum upon addition of the substrate androstenedione. When the cytochrome P-450-enriched fractions were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis and stained with Coomassie blue, there was an enrichment of two proteins having apparent molecular weights of 50,000 and 55,000. The bands containing these proteins were removed from unstained polyacrylamide gels and injected separately or together into three rabbits. An aliquot of the serum or an immunoglobulin (IgG) fraction prepared from the serum of the rabbit injected with the 55-kDa band or with both the 50- and 55-kDa bands inhibited aromatase activity of human placental microsomes by 80%; this IgG had no effect on 17 alpha-hydroxylase or 21-hydroxylase activities of human fetal adrenal microsomes. In contrast, the serum of the rabbit injected with the 50-kDa band had little capacity to inhibit placental aromatase activity. By immunoblot analysis, it was found that the IgG from the serum of the rabbit immunized with the 55-kDa protein bound specifically to a protein of 55 kDa in human placental microsomes. Monoclonal antibodies were prepared from a hybridoma cell line derived from the spleen cells of mice immunized against the 55-kDa protein. The monoclonal IgG was covalently linked to a Sepharose 4B column and was used for immunoaffinity chromatography of cytochrome P-450AROM. The finding that cytochrome P-450 and the 55-kDa protein were selectively retained by the affinity column and eluted with NaCl (2 M) and glycine (0.2 M, pH 3.0) and that this fraction contained aromatase activity upon reconstitution with purified NADPH-cytochrome P-450 reductase and phospholipid, is indicative that the 55-kDa protein is indeed cytochrome P-450AROM. These findings are also indicative that both the monoclonal and polyclonal IgGs are specific for human cytochrome P-450AROM.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4083898     DOI: 10.1016/0003-9861(85)90525-9

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  14 in total

1.  An aroma of complexity: how the unique genetics of aromatase (CYP19A1) explain diverse phenotypes from hens and hyenas to human gynecomastia, and testicular and other tumors.

Authors:  Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2013-12       Impact factor: 5.958

2.  A three-dimensional model of aromatase cytochrome P450.

Authors:  S Graham-Lorence; B Amarneh; R E White; J A Peterson; E R Simpson
Journal:  Protein Sci       Date:  1995-06       Impact factor: 6.725

3.  On the trail of steroid aromatase: The work of Kenneth J. Ryan.

Authors:  Martin J Spiering
Journal:  J Biol Chem       Date:  2019-07-12       Impact factor: 5.157

4.  Isolation of a full-length cDNA insert encoding human aromatase system cytochrome P-450 and its expression in nonsteroidogenic cells.

Authors:  C J Corbin; S Graham-Lorence; M McPhaul; J I Mason; C R Mendelson; E R Simpson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

5.  The immunocytochemical localisation and distribution of cytochrome P-450 in normal human hepatic and extrahepatic tissues with a monoclonal antibody to human cytochrome P-450.

Authors:  G I Murray; T S Barnes; H F Sewell; S W Ewen; W T Melvin; M D Burke
Journal:  Br J Clin Pharmacol       Date:  1988-04       Impact factor: 4.335

6.  Isolation and characterization of a complementary DNA specific for human aromatase-system cytochrome P-450 mRNA.

Authors:  C T Evans; D B Ledesma; T Z Schulz; E R Simpson; C R Mendelson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

7.  Testicular sex cord-stromal lesions: immunohistochemical analysis of cytokeratin, vimentin and steroidogenic enzymes.

Authors:  H Sasano; N Nakashima; O Matsuzaki; H Kato; S Aizawa; N Sasano; H Nagura
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

Review 8.  Regulation of aromatase expression in human tissues.

Authors:  S E Bulun; E R Simpson
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

9.  From Endocrinology to Intracrinology.

Authors:  Hironobu Sasano; Takashi Suzuki; Nobuhiro Harada
Journal:  Endocr Pathol       Date:  1998       Impact factor: 3.943

10.  Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries.

Authors:  Y Ito; C R Fisher; F A Conte; M M Grumbach; E R Simpson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.